Expertise in
2
conditions

Thomas F. Dejgaard

Copenhagen, DK 
Expertise in
2
conditions
Copenhagen, DK 

Overview

Thomas Dejgaard practices practicing medicine in Copenhagen, Denmark.

Mr. Dejgaard is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Pancreatectomy.

He is actively involved in clinical research, co-authoring 40 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Copenhagen, Denmark
Other Locations
Hellerup, Denmark
Hillerod, Denmark
Herlev, 2730, Denmark
Gentofte, Denmark
Hvidovre, Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Trial of Liraglutide Treatment in Subjects With Newly Diagnosed Type 1 Diabetes.
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre Trial of Liraglutide Treatment in Subjects With Newly Diagnosed Type 1 Diabetes.
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases: A Randomised, Placebo-controlled Trial
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases: A Randomised, Placebo-controlled Trial
Enrollment Status: Completed
Publish Date: July 10, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

40 Total Publications

Daily Glucagon-like Peptide-1 Receptor Agonists in Type 1 Diabetes: What we've Learned and What Comes Next.
Daily Glucagon-like Peptide-1 Receptor Agonists in Type 1 Diabetes: What we've Learned and What Comes Next.
Journal: Endocrinology and metabolism clinics of North America
Published: July 29, 2026

Frequently Asked Questions about Thomas F. Dejgaard

Is Thomas F. Dejgaard a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Thomas F. Dejgaard is classified as an Distinguished expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thomas F. Dejgaard participate in research or clinical trials?

Yes. Thomas F. Dejgaard has published 40 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Thomas F. Dejgaard's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dejgaard's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile